500 million working days are lost a year due to chronic pain in Europe, costing €300 billion a year. At NuroKor BioElectronics, we’ve worked hard to contribute to lowering statistics like these on occupational health hazards. This means we’re setting foot into a market projected to be worth $27Bn by 2022: wearable technology.
Research and development are at the heart of the work we’re doing at NuroKor BioElectronics. Our team believes the power is in the data. By equipping ourselves with specialised industry experts and arduously working in ongoing research we’re able to stay at the forefront of innovation within the electroceuticals market.
NuroKor CEO and Founder, Rick Rowan was a long term back pain sufferer, who knew there had to be something more than just pain killers to manage chronic and acute pain. After being introduced to a basic nerve stimulator machine, he saw the incredible potential of bioelectronics. But knew there was still more to be done to push the boundaries on electroceuticals beyond static waveforms. That’s how NuroKor BioElectronics was born.
Did you know the application of bioelectronic technology extends beyond humans?! NuroKor has quickly established itself as a key player in the animal care market. We have already established NuroKor Equine, and are currently working on alternatives for canine and feline care - with a focus on canine arthritis and wound care. This area of focus is still in its infancy, however, we are pushing forward through a heavy focus on R&D.
NuroKor BioElectronics is expanding into a variety of markets - including the area of aesthetics. Bioelectronic technology, like NuroKor, holds the potential to revolutionise this market, specifically in optimising aesthetics recovery post-surgery. This is soon to be developed territory and another space to watch in the NuroKor world.
Optimising recovery using bioelectronic technology is no longer a thing of the future. Check out this quick video with Chris Heron from The Engine Room to see the potential of bioelectronics for training and recovery.
Watch and learn how easy it is to use the KorGlov accessory with your NuroKor device.
Solicitor & NuroKor Investor, Amir Azimi shares the power of NuroKor Technology in the office and on the sports field
Solicitor and NuroKor advocate, Amir Azimi talks about how NuroKor technology has positively impacted the life of himself, his partner, and family members. He shares how the NuroKor helped him come back from a long-term injury and more.
Orthopaedic Surgeon and NuroKor Investor, Dr Raj Bhattacharya on the Clinical Applications of BioElectronics
Successful business man and NuroKor BioElectronics investor, Craig Terry has his sight set on becoming the fittest 70-year-old in the UK next year. In this video, Craig shares his passion for keeping his body and mind fit and the actions he is taking to stay healthy.
NuroKor BioElectronics technology benefits many professionals such as athletes and musicians. We interview Ric’key Pageot, Madonna’s accordion and keyboard player, who came to London for her Madame X Tour and also trialed NuroKor.
Former Wales, British and Irish Lions rugby international, Ieuan Evans talks about his investment in NuroKor as a project.
Original research from 2014 addressed whether electrical muscle stimulation is an alternative intervention to improve muscle recovery. It showed that neuromuscular stimulation training or NMS protocols have been proven to counteract muscle decline in seniors.
Lower back pain affects 540 million people globally. Bioelectrical medicine along with structured activity...